Diseases of the Respiratory Systems, Phase III

ARRC Trial

Volunteers
Health Professionals

What is the purpose of this trial?

The proposed study will be a randomized, double-blinded, placebo-controlled Phase III trial to examine the efficacy of AZM therapy relative to placebo in reducing RSV-related morbidity. Patients will be recruited during acute hospitalization and admission to the ICU at seven pediatric hospitals.

Trial with
University of Alabama at Birmingham
Ages
2 years and younger
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Michelle Ecarma, Research Coordinator

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Edward Vincent Faustino, MD, MHS
Professor of Pediatrics (Critical Care); Director of Trainee Research, Pediatrics; Chair, Pediatric Protocol Review Committee, Human Investigations Committee; Principal Investigator, Pathobiology, Epidemiology and Interventions against Thrombotic and Hemostatic Outcomes (PEITHO) Program, Pediatrics; Visiting Professor of Pediatrics (University of the Philippines College of Medicine)

Sub-Investigator

Richard Pierce, MD

Last Updated
08/12/2024
Study HIC
#2000031702